These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28731238)

  • 21. [PROLOGO: efalizumab].
    Vanaclocha Sebastián F
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():1. PubMed ID: 18341847
    [No Abstract]   [Full Text] [Related]  

  • 22. Practical experience of biologics for treatment of very severe psoriasis: a retrospective case cohort study of patients with a baseline Psoriasis Area and Severity Index greater than 20.
    Ponnambath N; Kalavala M; Anstey AV; Piguet V; Ingram JR
    Clin Exp Dermatol; 2016 Jan; 41(1):95-6. PubMed ID: 25817265
    [No Abstract]   [Full Text] [Related]  

  • 23. The journey of adult psoriasis patients towards biologics: past and present - Results from the BioCAPTURE registry.
    van den Reek JMPA; Seyger MMB; van Lümig PPM; Driessen RJB; Schalkwijk CJM; Berends MAM; van de Kerkhof PCM; de Jong EMGJ
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):615-623. PubMed ID: 29121430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are biologics useful for nail psoriasis?
    Antúnez-Lay A; Cabrolier J; Andino-Navarrete R
    Medwave; 2016 Jan; 16 Suppl 1():e6363. PubMed ID: 26817583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis.
    Levandoski KA; Quesenberry CP; Tsai AL; Asgari MM
    JAMA Dermatol; 2018 Feb; 154(2):218-219. PubMed ID: 29261840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From conventional to cutting edge: the new era of biologics in treatment of psoriasis.
    Tzu J; Kerdel F
    Dermatol Ther; 2008; 21(2):131-41. PubMed ID: 18394087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: results of a multicentre randomized controlled trial.
    Prinsen CA; Spuls PI; Lindeboom R; Sprangers MA; de Rie MA; de Korte J
    Br J Dermatol; 2015 Oct; 173(4):1091-4. PubMed ID: 25975387
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
    Reich K; Mrowietz U; Radtke MA; Thaci D; Rustenbach SJ; Spehr C; Augustin M
    Arch Dermatol Res; 2015 Dec; 307(10):875-83. PubMed ID: 26358263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study.
    Qiang JK; Shahbaz A; Kim W; Marinas J; Greaves S; Yeung J
    J Am Acad Dermatol; 2016 Jan; 74(1):176-7. PubMed ID: 26702799
    [No Abstract]   [Full Text] [Related]  

  • 30. New therapies under development for psoriasis treatment.
    García-Pérez ME; Stevanovic T; Poubelle PE
    Curr Opin Pediatr; 2013 Aug; 25(4):480-7. PubMed ID: 23838833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatment.
    Ribero S; Ortoncelli M; Mastorino L; Quaglino P; Dapavo P
    Expert Opin Biol Ther; 2023; 23(9):867-868. PubMed ID: 37553946
    [No Abstract]   [Full Text] [Related]  

  • 32. New horizons in the management of psoriasis: introduction.
    Lebwohl M
    Cutis; 1998 Feb; 61(2 Suppl):7. PubMed ID: 9787985
    [No Abstract]   [Full Text] [Related]  

  • 33. Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network.
    van den Reek JM; van Lüumig PP; Otero ME; Zweegers J; van de Kerkhof PC; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; Seyger MM; Kievit W; de Jong EM
    Br J Dermatol; 2014 May; 170(5):1158-65. PubMed ID: 24484403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resource use in patients with psoriasis after the introduction of biologics in Sweden.
    Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
    Acta Derm Venereol; 2015 Feb; 95(2):156-61. PubMed ID: 24819980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?
    Alwawi EA; Krulig E; Gordon KB
    Dermatol Ther; 2009; 22(5):431-40. PubMed ID: 19845720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new era in the management of psoriasis? The biologics: facts and controversies.
    Ferrándiz C; Carrascosa JM; Boada A
    Clin Dermatol; 2010; 28(1):81-7. PubMed ID: 20082956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials.
    Reich K; Burden AD; Eaton JN; Hawkins NS
    Br J Dermatol; 2012 Jan; 166(1):179-88. PubMed ID: 21910698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum fatty acid-binding protein 4 level is inversely correlated with serum thymus and activation-regulated chemokine level in psoriatic patients achieving clear skin by biologics.
    Honma M; Shibuya T; Iinuma S; Ishida-Yamamoto A
    J Dermatol; 2019 Apr; 46(4):e116-e117. PubMed ID: 30216494
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real-life practice: The Resoswitch study.
    Dabouz F; Khemis A; Barbe C; Lahfa M; Maccari F; Chaby G; Beneton N; Boye T; Esteve E; Mahé E; Begon E; Pauwels C; Bernard P; Taieb C; Reguiai Z;
    Dermatol Ther; 2019 Mar; 32(2):e12789. PubMed ID: 30488520
    [No Abstract]   [Full Text] [Related]  

  • 40. The management of moderate-to-severe chronic plaque psoriasis.
    Tonini A; Panduri S; D' Erme AM; Papadia F; Romanelli M; Krueger JG; Chiricozzi A
    G Ital Dermatol Venereol; 2017 Oct; 152(5):447-457. PubMed ID: 28534602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.